Modeling Tumor Clonal Evolution for Drug Combinations Design
about
Differential selective pressure alters rate of drug resistance acquisition in heterogeneous tumor populations.A population genetics perspective on the determinants of intra-tumor heterogeneity.Extended Adjuvant Endocrine Therapy for Postmenopausal Women: Treating Many to Benefit a Few.Variable Cell Line Pharmacokinetics Contribute to Non-Linear Treatment Response in Heterogeneous Cell Populations.Exploiting vulnerabilities in cancer signalling networks to combat targeted therapy resistance
P2860
Modeling Tumor Clonal Evolution for Drug Combinations Design
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Modeling Tumor Clonal Evolution for Drug Combinations Design
@ast
Modeling Tumor Clonal Evolution for Drug Combinations Design
@en
type
label
Modeling Tumor Clonal Evolution for Drug Combinations Design
@ast
Modeling Tumor Clonal Evolution for Drug Combinations Design
@en
prefLabel
Modeling Tumor Clonal Evolution for Drug Combinations Design
@ast
Modeling Tumor Clonal Evolution for Drug Combinations Design
@en
P2860
P1433
P1476
Modeling Tumor Clonal Evolution for Drug Combinations Design
@en
P2093
Boyang Zhao
Michael T Hemann
P2860
P304
P356
10.1016/J.TRECAN.2016.02.001
P577
2016-03-01T00:00:00Z